These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10863658)

  • 21. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era.
    Korhonen P; Laitinen J; Hyödynmaa E; Tammela O
    Acta Paediatr; 2004 Mar; 93(3):316-21. PubMed ID: 15124832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health and hospitalistions after discharge in extremely low birth weight infants.
    Doyle LW; Ford G; Davis N
    Semin Neonatol; 2003 Apr; 8(2):137-45. PubMed ID: 15001150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the sequence of pulmonary injury in the extremely low birth weight, surfactant-deficient infant.
    Peterson SW
    Neonatal Netw; 2009; 28(4):221-9; quiz 255-8. PubMed ID: 19592363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchopulmonary dysplasia: A review of the pulmonary sequelae in the post-surfactant era.
    Haggie S; Robinson P; Selvadurai H; Fitzgerald DA
    J Paediatr Child Health; 2020 May; 56(5):680-689. PubMed ID: 32270551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants.
    Latini G; De Felice C; Giannuzzi R; Del Vecchio A
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S69-73. PubMed ID: 23809356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal prevention of bronchopulmonary dysplasia.
    Greenough A; Ahmed N
    J Perinat Med; 2013 Jan; 41(1):119-26. PubMed ID: 23096098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years.
    Theile AR; Radmacher PG; Anschutz TW; Davis DW; Adamkin DH
    J Perinatol; 2012 Feb; 32(2):117-22. PubMed ID: 21617642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Multiple Ventilation Courses and Duration of Mechanical Ventilation on Respiratory Outcomes in Extremely Low-Birth-Weight Infants.
    Jensen EA; DeMauro SB; Kornhauser M; Aghai ZH; Greenspan JS; Dysart KC
    JAMA Pediatr; 2015 Nov; 169(11):1011-7. PubMed ID: 26414549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchopulmonary dysplasia. Impact of surfactant replacement therapy.
    McColley SA
    Pediatr Clin North Am; 1998 Jun; 45(3):573-86. PubMed ID: 9653437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.
    Lista G; Maturana A; Moya FR
    Eur J Pediatr; 2017 Oct; 176(10):1287-1293. PubMed ID: 28795220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?
    Aly H; Milner JD; Patel K; El-Mohandes AA
    Pediatrics; 2004 Sep; 114(3):697-702. PubMed ID: 15342841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
    Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence.
    Poets CF; Lorenz L
    Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F285-F291. PubMed ID: 29363502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the postsurfactant era.
    Kaplan E; Bar-Yishay E; Prais D; Klinger G; Mei-Zahav M; Mussaffi H; Steuer G; Hananya S; Matyashuk Y; Gabarra N; Sirota L; Blau H
    Chest; 2012 Sep; 142(3):725-733. PubMed ID: 22423043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks.
    Choukroun ML; Feghali H; Vautrat S; Marquant F; Nacka F; Leroy V; Demarquez JL; Fayon MJ
    Respir Med; 2013 Dec; 107(12):1966-76. PubMed ID: 23880413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catch-up growth in the first two years of life in Extremely Low Birth Weight (ELBW) infants is associated with lower body fat in young adolescence.
    Raaijmakers A; Jacobs L; Rayyan M; van Tienoven TP; Ortibus E; Levtchenko E; Staessen JA; Allegaert K
    PLoS One; 2017; 12(3):e0173349. PubMed ID: 28278233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants.
    Foglia EE; Jensen EA; Kirpalani H
    J Perinatol; 2017 Nov; 37(11):1171-1179. PubMed ID: 28569744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.